- China Pharmaceutical University
Dr. Xiaosheng Wang received his Ph.D. in Bioinformatics from Kyoto University, Japan in 2010, worked as a postdoctoral researcher at the National Institutes of Health (NIH/NCI) in the U.S. from 2010 to 2013, and worked at the University of Nebraska Medical Center (UNMC) in the U.S. from 2013 to 2015 as an instructor. Currently, he is the director of the Biomedical Informatics Lab, School of Basic Medicine and Clinic Pharmacy, China Pharmaceutical University. Dr. Wang’s main research interests include: the development of algorithms and databases for analysis of omics data; epidemiological and genomics studies of COVID-19; study of immuno-oncology based on cancer genomics data; discovery of predictive biomarkers for cancer immunotherapy response; systems and computational biology for elucidating the nature of oncogenesis; inference of molecular interaction networks relevant to specific diseases. He has published nearly 60 papers in SCI-indexed journals, including Journal for ImmunoTherapy of Cancer, Briefings in Bioinformatics, Nature Communications, Oncogene, npj Precision Oncology, Clinical and Translational Medicine, Science of The Total Environment, Computational and Structural Biotechnology Journal, Journal of Experimental & Clinical Cancer Research, EBioMedicine, Cellular Oncology, Frontiers in Immunology, Journal of Neuroinflammation, and Communications Biology.
Channels contributed to:Behind the paper